Literature DB >> 31656777

Bleeding in patients with atrial fibrillation treated with combined antiplatelet and anticoagulant therapy: time to turn the corner.

Ke Xu1, Noel C Chan2.   

Abstract

Entities:  

Year:  2019        PMID： 31656777      PMCID： PMC6789336          DOI： 10.21037/atm.2019.07.40

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  25 in total

Review 1.  2018 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation.

Authors:  Jason G Andrade; Atul Verma; L Brent Mitchell; Ratika Parkash; Kori Leblanc; Clare Atzema; Jeff S Healey; Alan Bell; John Cairns; Stuart Connolly; Jafna Cox; Paul Dorian; David Gladstone; M Sean McMurtry; Girish M Nair; Louise Pilote; Jean-Francois Sarrazin; Mike Sharma; Allan Skanes; Mario Talajic; Teresa Tsang; Subodh Verma; D George Wyse; Stanley Nattel; Laurent Macle
Journal:  Can J Cardiol       Date:  2018-11       Impact factor: 5.223

2.  2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.

Authors:  Craig T January; L Samuel Wann; Hugh Calkins; Lin Y Chen; Joaquin E Cigarroa; Joseph C Cleveland; Patrick T Ellinor; Michael D Ezekowitz; Michael E Field; Karen L Furie; Paul A Heidenreich; Katherine T Murray; Julie B Shea; Cynthia M Tracy; Clyde W Yancy
Journal:  J Am Coll Cardiol       Date:  2019-01-28       Impact factor: 24.094

3.  Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study.

Authors:  Leif Friberg; Mårten Rosenqvist; Gregory Y H Lip
Journal:  Eur Heart J       Date:  2012-01-13       Impact factor: 29.983

4.  Major Bleeding Rates in Atrial Fibrillation Patients on Single, Dual, or Triple Antithrombotic Therapy.

Authors:  Nienke van Rein; Uffe Heide-Jørgensen; Willem M Lijfering; Olaf M Dekkers; Henrik T Sørensen; Suzanne C Cannegieter
Journal:  Circulation       Date:  2019-02-05       Impact factor: 29.690

5.  Concomitant use of antiplatelet therapy with dabigatran or warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial.

Authors:  Antonio L Dans; Stuart J Connolly; Lars Wallentin; Sean Yang; Juliet Nakamya; Martina Brueckmann; Michael Ezekowitz; Jonas Oldgren; John W Eikelboom; Paul A Reilly; Salim Yusuf
Journal:  Circulation       Date:  2012-12-27       Impact factor: 29.690

6.  Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation.

Authors:  S Yusuf; F Zhao; S R Mehta; S Chrolavicius; G Tognoni; K K Fox
Journal:  N Engl J Med       Date:  2001-08-16       Impact factor: 91.245

7.  Pantoprazole to Prevent Gastroduodenal Events in Patients Receiving Rivaroxaban and/or Aspirin in a Randomized, Double-Blind, Placebo-Controlled Trial.

Authors:  Paul Moayyedi; John W Eikelboom; Jackie Bosch; Stuart J Connolly; Leanne Dyal; Olga Shestakovska; Darryl Leong; Sonia S Anand; Stefan Störk; Kelly R H Branch; Deepak L Bhatt; Peter B Verhamme; Martin O'Donnell; Aldo P Maggioni; Eva M Lonn; Leopoldo S Piegas; Georg Ertl; Matyas Keltai; Nancy Cook Bruns; Eva Muehlhofer; Gilles R Dagenais; Jae-Hyung Kim; Masatsugu Hori; P Gabriel Steg; Robert G Hart; Rafael Diaz; Marco Alings; Petr Widimsky; Alvaro Avezum; Jeffrey Probstfield; Jun Zhu; Yan Liang; Patricio Lopez-Jaramillo; Ajay Kakkar; Alexander N Parkhomenko; Lars Ryden; Nana Pogosova; Antonio Dans; Fernando Lanas; Patrick J Commerford; Christian Torp-Pedersen; Tomek Guzik; Dragos Vinereanu; Andrew M Tonkin; Basil S Lewis; Camilo Felix; Khalid Yusoff; Kaj Metsarinne; Keith A A Fox; Salim Yusuf
Journal:  Gastroenterology       Date:  2019-05-02       Impact factor: 22.682

8.  Clinical outcomes and management associated with major bleeding in patients with atrial fibrillation treated with apixaban or warfarin: insights from the ARISTOTLE trial.

Authors:  Claes Held; Elaine M Hylek; John H Alexander; Michael Hanna; Renato D Lopes; Daniel M Wojdyla; Laine Thomas; Hussein Al-Khalidi; Marco Alings; Dennis Xavier; Jack Ansell; Shinya Goto; Witold Ruzyllo; Mårten Rosenqvist; Freek W A Verheugt; Jun Zhu; Christopher B Granger; Lars Wallentin
Journal:  Eur Heart J       Date:  2014-12-12       Impact factor: 29.983

9.  Ticagrelor versus clopidogrel in patients with acute coronary syndromes.

Authors:  Lars Wallentin; Richard C Becker; Andrzej Budaj; Christopher P Cannon; Håkan Emanuelsson; Claes Held; Jay Horrow; Steen Husted; Stefan James; Hugo Katus; Kenneth W Mahaffey; Benjamin M Scirica; Allan Skene; Philippe Gabriel Steg; Robert F Storey; Robert A Harrington; Anneli Freij; Mona Thorsén
Journal:  N Engl J Med       Date:  2009-08-30       Impact factor: 91.245

10.  Balancing the benefits and risks of 2 doses of dabigatran compared with warfarin in atrial fibrillation.

Authors:  John W Eikelboom; Stuart J Connolly; Robert G Hart; Lars Wallentin; Paul Reilly; Jonas Oldgren; Sean Yang; Salim Yusuf
Journal:  J Am Coll Cardiol       Date:  2013-06-13       Impact factor: 24.094
View more
  3 in total

1.  Emergent cholecystectomy in patients on antithrombotic therapy.

Authors:  Masashi Yoshimoto; Masayoshi Hioki; Hiroshi Sadamori; Kazuteru Monden; Satoshi Ohno; Norihisa Takakura
Journal:  Sci Rep       Date:  2020-06-22       Impact factor: 4.379

2.  Taking antithrombic therapy during emergency laparoscopic cholecystectomy for acute cholecystitis does not affect the postoperative outcomes: a propensity score matched study.

Authors:  Kentaro Oji; Yasunori Otowa; Yuta Yamazaki; Keisuke Arai; Yasuhiko Mii; Keitaro Kakinoki; Tetsu Nakamura; Daisuke Kuroda
Journal:  BMC Surg       Date:  2022-02-05       Impact factor: 2.102

3.  Direct versus conventional anticoagulants for treatment of cancer associated thrombosis: a pooled and interaction analysis between observational studies and randomized clinical trials.

Authors:  Zhi-Chun Gu; Yi-Dan Yan; Sheng-Yan Yang; Long Shen; Ling-Cong Kong; Chi Zhang; An-Hua Wei; Zheng Li; Xin-Hua Wang; Hou-Wen Lin
Journal:  Ann Transl Med       Date:  2020-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.